Areas of Focus
- Viral Vaccines
- Therapeutic Antibodies
- Antiviral Drugs
Work Experience
- 2023-10 to present - Chinese Academy of Sciences Shanghai Institute of Immunology and Infection - Researcher
- 2019-03 to 2023-09 - Chinese Academy of Sciences Shanghai Institute of Immunology and Infection (formerly Shanghai Pasteur Institute) - Associate Researcher
- 2014-12 to 2019-03 - Hebei Medical University - Associate Professor
- 2013-09 to 2016-07 - Chinese Center for Disease Control and Prevention - PhD Student
- 2009-12 to 2014-12 - Hebei Medical University - Lecturer
- 2007-07 to 2009-12 - Hebei Medical University - Assistant Lecturer
Academic Background & Achievements
- 2013-09 to 2016-07 PhD: Chinese Center for Disease Control and Prevention
- 2004-09 to 2007-07 Master's: Hebei Medical University
- 1999-09 to 2004-07 Bachelor's: Hebei Medical University
Publications
- Extracellular Disintegration of Viral Proteins as an Innovative Strategy for Developing Broad-Spectrum Antivirals Against Coronavirus, Jiaming Lan, 2024
- Both chimpanzee adenovirus-based and DNA vaccines induced long-term immunity and conferred complete protection against Nipah virus infection, Jiaming Lan, 2023
- Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection, Jiaming Lan, 2023
- Recombinant Chimpanzee Adenovirus Vector Vaccine Expressing the Spike Protein Provides Effective and Lasting Protection against SARS-CoV-2 Infection, Jiaming Lan, 2022
- Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2, Jiaming Lan, 2022
- A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection, Jiaming Lan, 2021
- Clinical and Laboratory-Derived Parameters of 119 Hospitalized Patients with Coronavirus Disease 2019 in Xiangyang, Hubei Province, China., Jiaming Lan, 2020
- Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections, Jiaming Lan, 2020
- Progress on Research Tools of Coronaviruses, Jiaming Lan, 2020
- Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression, Jiaming Lan, 2020
- Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus, Jiaming Lan, 2018
- Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus, Jiaming Lan, 2018
- The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection, Jiaming Lan, 2017
- Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8(+) T Cell Epitopes and Host MHC, Jiaming Lan, 2017
- Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge, Jiaming Lan, 2015
- Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen, Jiaming Lan, 2014
- Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination, Jiaming Lan, 2011
Awards
- CVB3 Vaccine Series Research (2012): Third Prize, Municipal Level
